Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management

Journal Title: Нирки - Year 2018, Vol 7, Issue 4

Abstract

.

Authors and Affiliations

Keywords

Related Articles

Effectiveness of pantocrinum in the complex treatment of chronic kidney disease

The dynamics of chronic renal disease is presented for 25 patients, taking into account the effectiveness of Pantocrine. The study involved patients with chronic renal disease from I to V stages of different nosological...

The Experience of Combination Phytotherapy in Patients with Urethrolithiasis

In the article the attention was paid to one of the most urgent problems of modern medicine — urolithiasis. One component of the pharmacotherapy of this disease is phytotherapy. This article provides an experience of use...

Results of Differential Treatment of Tenckhoff Catheter Exit Site/Tunnel Infection during Peritoneal Dialysis in Patients with End-Stage Chronic Kidney Disease

Introduction. Tenckhoff catheter exit site infection (ESI) occurs in 0.05–1.05 cases per patient per year and is a risk factor of termination of peritoneal dialysis (PD). Objective of the work. To evaluate the efficacy o...

Download PDF file
  • EP ID EP421434
  • DOI 10.22141/2307-1257.7.4.2018.148514
  • Views 60
  • Downloads 0

How To Cite

(2018). Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management. Нирки, 7(4), 261-268. https://europub.co.uk/articles/-A-421434